What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Immune system
Luigi D. Notarangelo mainly investigates Immunology, Severe combined immunodeficiency, Immunodeficiency, Mutation and Transplantation.
His studies in Immunology integrate themes in fields like Genetic enhancement and CD40.
His Severe combined immunodeficiency research is multidisciplinary, incorporating perspectives in Hematopoietic stem cell transplantation, Janus kinase 3, DCLRE1C, Omenn syndrome and Bone marrow.
His Immunodeficiency research includes themes of Gene rearrangement and Bioinformatics.
His Mutation research incorporates themes from Osteopetrosis, Regulation of gene expression, CLCN7 and RAG2.
He studied Transplantation and Humoral immunity that intersect with Interleukin 4.
His most cited work include:
- Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). (1344 citations)
- Diagnostic Criteria for Primary Immunodeficiencies (845 citations)
- The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM (818 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Severe combined immunodeficiency, Immunodeficiency, Immune system and Primary immunodeficiency.
The Immunology study combines topics in areas such as Hematopoietic stem cell transplantation, Transplantation and Omenn syndrome.
He works mostly in the field of Omenn syndrome, limiting it down to topics relating to Mutation and, in certain cases, Molecular biology, as a part of the same area of interest.
Luigi D. Notarangelo has included themes like Janus kinase 3, Genetic enhancement and Newborn screening in his Severe combined immunodeficiency study.
His research in Immunodeficiency intersects with topics in Immune dysregulation, Common variable immunodeficiency and Virology.
His Primary immunodeficiency study is concerned with the field of Disease as a whole.
He most often published in these fields:
- Immunology (64.42%)
- Severe combined immunodeficiency (26.42%)
- Immunodeficiency (22.28%)
What were the highlights of his more recent work (between 2018-2021)?
- Immunology (64.42%)
- Immune system (19.52%)
- Immune dysregulation (7.25%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immunology, Immune system, Immune dysregulation, Severe combined immunodeficiency and Immunodeficiency.
Immunology is often connected to Disease in his work.
His Immune system research focuses on Receptor and how it relates to Virus.
Luigi D. Notarangelo combines subjects such as X-linked severe combined immunodeficiency, Primary immunodeficiency, Transduction and Bioinformatics with his study of Immune dysregulation.
The various areas that Luigi D. Notarangelo examines in his Severe combined immunodeficiency study include Phenotype, Hematopoietic stem cell transplantation, Genetic enhancement and Omenn syndrome.
He interconnects Mutation, Missense mutation, Medical microbiology, Recombination-activating gene and Lymphocyte in the investigation of issues within Immunodeficiency.
Between 2018 and 2021, his most popular works were:
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
- Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. (276 citations)
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection. (72 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
His primary areas of study are Immunology, Severe combined immunodeficiency, CD8, Immune system and Primary immunodeficiency.
His work deals with themes such as Disease and Pneumonia, which intersect with Immunology.
In his study, which falls under the umbrella issue of Severe combined immunodeficiency, Induced pluripotent stem cell, Adenosine deaminase deficiency, Enzyme replacement therapy and Newborn screening is strongly linked to Hematopoietic stem cell transplantation.
His CD8 study incorporates themes from Cancer research, Haploinsufficiency, Gene dosage, DiGeorge syndrome and T-cell receptor excision circles.
The concepts of his Immune system study are interwoven with issues in Receptor and Plasma cell.
His Primary immunodeficiency research is multidisciplinary, incorporating elements of Inflammatory Bowel Diseases, Inflammatory bowel disease, Chronic granulomatous disease, Allogeneic hct and Treatment outcome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
